Global S&T Development Trend Analysis Platform of Resources and Environment
EXPERT COMMENTARY: COVID19 | |
admin | |
2020-04-06 | |
发布年 | 2020 |
语种 | 英语 |
国家 | 澳大利亚 |
领域 | 地球科学 |
正文(英文) | Additional ResourcesAdditional Resources;This page was last updated 6 April 2020.
How humans fight the virusMelbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection published in Nature (16 March 2020). This is a great breakthrough from the Doherty Institute. Understanding how the virus behaves in humans allows us to understand what drugs may work and how to shape a more effective vaccine. When a vaccine candidate moves to clinical trials, this knowledge will enable researchers to move at speed in the final steps of testing a vaccine for safety and efficacy. - Dr Rob Grenfell Understanding the virus
Our first challenge is understanding this new virus. Since SARS, we have new techniques to understand what is going on inside the virus and at a molecular level, and also more technology to understand what is going on, on the surface of the virus. However, it’s important to find out how it behaves in biological systems. As we are beginning to have a better understanding of the virus, the CSIRO team can soon begin testing new potential vaccines and therapeutics being developed by others to see if they work and are safe. Changes in the virus
This virus belongs to a group of viruses that exist not as a single virus but as a cloud of subtly different ones and if it finds a new niche to occupy, it will do that and slowly get better at replicating in the new host or alternatively it might die out. Surgical face masksWe are working together with the Australian Government and Victorian manufacturers’ Textor Technologies and Med-Con in an effort to build local capability and supply of materials to rapidly address demand for medical materials needed to respond to COVID-19. Study on the genome sequence changes of the novel coronavirusWe have analysed the 181 published genome sequences from the current COVID-19 outbreak to understand how changes in the virus affect its behaviour and impact. We have confirmed the virus is evolving into a number of distinct clusters in different parts of the world. At this time, we do not think it will affect the development and evaluation of COVID-19 vaccines, therapies and diagnostics, but we will continue to closely monitor the situation. - Prof S.S. Vasan CSIRO has adapted bioinformatics algorithms, first developed for the human genome, to tackle the problem efficiently. However, this only gives us a picture of the general genomic variability rather than the individual functional consequences. For example, it is very likely that disease severity is a combination of personal predispositions as well as viral properties. The team are hence calling on the international community to share more genomic sequences of the virus alongside de-identified information about clinical symptoms and co-morbidities. This will help monitor the changes and form a better understanding of how important genetic differences are to the disease’s progression, potentially leading to better diagnostics and treatment. - A/Prof Denis Bauer Testing potential vaccines and therapeuticsCSIRO has been commissioned to develop a system so that anyone with a candidate vaccine (a vaccine that they think will work but hasn’t yet had proof of efficacy) can just plug it into our system and make the process of testing faster. It is quite a challenge for us to get this set up, but we hope we’ll have something ready for vaccine producers to use by March or April this year. - Prof Trevor Drew - Dr Rob Grenfell We have designed a staggered challenge study to get timely information on vaccine efficacy, initially with just the prime dose, followed closely by prime and boost. With the Oxford candidate, we are exploring if intranasal administration induces tissue resident immunity to help clear the infection more readily or rapidly. These are mission critical objectives in the current pandemic situation where the number of cases globally, as of 25 March, are doubling roughly every 8 days and the number of deaths roughly every 6-7 days. - Prof S.S. Vasan Manufacture of a vaccineAt CSIRO’s state-of-the-art biologics production facility in Melbourne, scientists will begin small-scale production of a vaccine candidate for coronavirus designed at the University of Queensland (UQ). After the initial small-scale testing, we will scale up production of the vaccine candidate using best-practice manufacturing standards for UQ to continue with the next stage of toxicology studies and testing. - Prof George Lovrecz University of Queensland’s development of a vaccine candidateWe congratulate the University of Queensland (UQ) on the creation of the vaccine candidate for coronavirus, COVID-19, which was achieved in just three weeks. A huge early achievement in the rapid response to the coronavirus outbreak. UQ’s vaccine candidate will now move to further testing at CSIRO’s state-of-the-art biologics production facility in Melbourne where our scientists have begun small-scale testing. Vaccine development for coronavirus is being done through the Coalition for Epidemic Preparedness Innovations (CEPI), which has funded four consortia so far, one of which is led by The University of Queensland (UQ). - Dr Rob Grenfell Time to develop a vaccine
The timeline of developing a vaccine in merely months is very fast. That’s because we started this race with most of the tools partly developed. HarmfulnessWhen a new infection first makes a transition to a new species, when it jumps from animals to humans, the virus goes through a phase of demonstrating what it is capable of doing. This one appeared as being very infectious. The concern is that we don’t know fully yet how this virus is going to behave because it is new, and we don’t know what animals may carry it. - Dr Rob Grenfell - Prof Trevor Drew Infection ratesThe virus is very contagious meaning it is efficient in how it spreads. With the research we’re undertaking we’re aiming to get a better understanding of transmission of the virus. At this stage transmission rates are yet to be formally determined. - Prof Trevor Drew Origins of the virus
We don’t know where the virus originated from – this is yet to be determined. CSIRO is looking to identify the possible animal carrier/host of the novel coronavirus. CSIRO has a history of this type of research, as previously our scientists identified bats as the natural reservoir of Severe Acute Respiratory Syndrome (SARS)-like coronaviruses. - Prof Trevor Drew We have been working to try to understand how bats co-exist with viruses without disease and will be very interested to learn more about the role of bats in the emergence of this new virus. SARS-CoV-2. - Dr Michelle Baker What is coronavirusCoronavirus is an umbrella terms for a group of viruses that can cause illnesses such as the common cold, gastrointestinal infections, and diseases including SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome). They are found in a wide range of different animal hosts, including birds and reptiles and most are specific for a particular host. But, occasionally, these viruses can jump host, as in this case. Coronaviruses get their name from their appearance. The viruses look like they are covered with pointed structures that surround them like a corona, or crown, when viewed under a microscope. - Prof Trevor Drew Response effortsThere is still so much we don’t know about this new virus. It is very new to its human host – we don’t know yet how it will behave. A cautionary approach is prudent until we know more. We’re in regular communication with the Australian National Operations Office to keep them informed on the status of our work and have made ourselves available to assist where needed. - Prof Trevor Drew Our experts
|
URL | 查看原文 |
来源平台 | Commonwealth Scientific and Industrial Research Organisation |
文献类型 | 新闻 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/273925 |
专题 | 地球科学 |
推荐引用方式 GB/T 7714 | admin. EXPERT COMMENTARY: COVID19. 2020. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[admin]的文章 |
百度学术 |
百度学术中相似的文章 |
[admin]的文章 |
必应学术 |
必应学术中相似的文章 |
[admin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论